Free tool
FAERS Monitor: Skyla
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203159 or its brand name (Skyla, Levonorgestrel). Reports on generic versions are filed under their own applications.
Reports
8,862
Serious
4,759
54% of reports
Hospitalization
812
Death reported
59
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- device expulsion1,329
- drug ineffective1,256
- device dislocation814
- pregnancy with contraceptive device700
- genital haemorrhage676
- abdominal pain lower488
- procedural pain312
- expired device used309
- vaginal haemorrhage299
- nausea284
- complication of device insertion258
- ectopic pregnancy with contraceptive device251
- abdominal pain244
- headache228
- pain213
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 39 |
| 2005 | 39 |
| 2006 | 37 |
| 2007 | 27 |
| 2008 | 22 |
| 2009 | 45 |
| 2010 | 64 |
| 2011 | 93 |
| 2012 | 101 |
| 2013 | 133 |
| 2014 | 351 |
| 2015 | 729 |
| 2016 | 848 |
| 2017 | 939 |
| 2018 | 865 |
| 2019 | 660 |
| 2020 | 644 |
| 2021 | 628 |
| 2022 | 677 |
| 2023 | 625 |
| 2024 | 524 |
| 2025 | 427 |
| 2026 | 345 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,297 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| ectopic pregnancy with contraceptive deviceSignal | 251 | 410.0 | 359.1 | 86,981 |
| expired device usedSignal | 309 | 243.8 | 217.3 | 67,549 |
| pregnancy with contraceptive deviceSignal | 700 | 201.1 | 186.7 | 128,367 |
| genital haemorrhageSignal | 676 | 131.6 | 122.1 | 82,940 |
| device expulsionSignal | 1,329 | 49.6 | 47.2 | 62,179 |
| abdominal pain lowerSignal | 488 | 46.7 | 42.8 | 21,383 |
| device dislocationSignal | 814 | 45.3 | 42.4 | 34,603 |
| complication of device insertionSignal | 258 | 31.2 | 27.6 | 7,413 |
| procedural painSignal | 312 | 27.0 | 24.2 | 7,705 |
| vaginal haemorrhageSignal | 299 | 16.5 | 14.7 | 4,304 |
| abdominal painSignal | 244 | 2.5 | 2.2 | 218 |
| drug ineffectiveSignal | 1,256 | 2.3 | 2.1 | 942 |
| headache | 228 | 0.9 | 0.8 | 5 |
| nausea | 284 | 0.9 | 0.8 | 7 |
| pain | 213 | 0.8 | 0.7 | 8 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.